These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid. Day RO; McLachlan AJ; Graham GG; Williams KM Clin Pharmacokinet; 1999 Mar; 36(3):191-210. PubMed ID: 10223168 [TBL] [Abstract][Full Text] [Related]
3. Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid. Netter P; Bannwarth B; Royer-Morrot MJ Clin Pharmacokinet; 1989 Sep; 17(3):145-62. PubMed ID: 2680211 [TBL] [Abstract][Full Text] [Related]
4. Current nonsteroidal anti-inflammatory drug applications for rheumatic diseases. Kantor TG Prim Care; 1993 Dec; 20(4):955-63. PubMed ID: 8310091 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of non steroidal anti-inflammatory drugs in synovial fluid. Netter P; Bannwarth B; Lapicquel F; Demotes-Mainard F; Schceverbeke T; Gillet P Agents Actions Suppl; 1993; 44():45-50. PubMed ID: 8372734 [TBL] [Abstract][Full Text] [Related]
7. Nonsteroidal antiinflammatory drugs in treatment of osteoarthritis. Brandt KD; Slowman-Kovacs S Clin Orthop Relat Res; 1986 Dec; (213):84-91. PubMed ID: 3780106 [TBL] [Abstract][Full Text] [Related]
8. Tolerability of nabumetone: a pilot in vitro study showing absence of injury to articular cartilage. Giordano N; Senesi M; Battisti E; Gonnelli S; Franci B; Campagna MS; Mattii G; Palumbo F; Gennari C Int J Tissue React; 1996; 18(4-6):105-8. PubMed ID: 9195245 [TBL] [Abstract][Full Text] [Related]
12. Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs. Lin JH; Cocchetto DM; Duggan DE Clin Pharmacokinet; 1987 Jun; 12(6):402-32. PubMed ID: 3301150 [TBL] [Abstract][Full Text] [Related]
13. Cartilage metabolism and anti-inflammatory drugs in osteoarthritis. Hess EV; Herman JH Am J Med; 1986 Nov; 81(5B):36-43. PubMed ID: 3538869 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of NSAIDs on joint destruction in osteoarthritis. Rainsford KD Agents Actions Suppl; 1993; 44():39-43. PubMed ID: 8372733 [TBL] [Abstract][Full Text] [Related]
15. [Articular chondroprotection]. Borrachero del Campo J An R Acad Nac Med (Madr); 1987; 104(4):467-80. PubMed ID: 3328523 [No Abstract] [Full Text] [Related]
16. Historical overview of NSAIDs. Wright V Eur J Rheumatol Inflamm; 1993; 13(1):4-6. PubMed ID: 7821338 [TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory and cartilage-protecting effects of an intra-articularly injected anti-TNF{alpha} single-chain Fv antibody (ESBA105) designed for local therapeutic use. Urech DM; Feige U; Ewert S; Schlosser V; Ottiger M; Polzer K; Schett G; Lichtlen P Ann Rheum Dis; 2010 Feb; 69(2):443-9. PubMed ID: 19293161 [TBL] [Abstract][Full Text] [Related]
18. Transsynovial drug distribution: synovial mean transit time of diclofenac and other nonsteroidal antiinflammatory drugs. Elmquist WF; Chan KK; Sawchuk RJ Pharm Res; 1994 Dec; 11(12):1689-97. PubMed ID: 7899229 [TBL] [Abstract][Full Text] [Related]